Skip to main content
. Author manuscript; available in PMC: 2018 Mar 23.
Published in final edited form as: Gynecol Oncol. 2010 Nov 13;120(2):214–219. doi: 10.1016/j.ygyno.2010.09.025

Table 4.

Participant-generated symptoms and their perceived importance.

Symptom/concern Rank % of Responses (N) Mean importance rating (0–10) Symptom currently in checklist
Fatigue 1 43 (12) 7.7 Yes
Nausea 2 39 (11) 8.6 Yes
Pain 3 36 (10) 6.5 Yes
Constipation 4 21 (6) 8.0 Yes
Hair loss 4 21 (6) 7.2 No
Neuropathy 6 18 (5) 10.0 No
Patient–doctor communication 6 18 (5) 9.2 No
Diarrhea 8 14 (4) 8.8 No
Effects of chemotherapy 8 14 (4) 9.3 No

Note. N=28.